Literature DB >> 9219559

Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors.

D R Germolec1, J Spalding, G A Boorman, J L Wilmer, T Yoshida, P P Simeonova, A Bruccoleri, F Kayama, K Gaido, R Tennant, F Burleson, W Dong, R W Lang, M I Luster.   

Abstract

Although numerous epidemiological studies have shown that inorganic arsenicals are human skin carcinogens, there is currently no accepted mechanism for its action or an established animal model for its study. We observed increased mRNA transcripts and secretion of keratinocyte growth factors, including granulocyte macrophage-colony stimulating factor (GM-CSF) and transforming growth factor-alpha (TGF-alpha) and the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) in primary human epidermal keratinocytes cultured in the presence of low micromolar concentrations of sodium arsenite. Total cell numbers, as well as c-myc expression and incorporation of [3H]thymidine, both indicators of cell proliferation, were also elevated in keratinocyte cultures treated with sodium arsenite. As an in vivo model, the influence of arsenic on mouse skin tumor development was studied in transgenic TG.AC mice which carry the v-Ha-ras oncogene, and can serve as a genetically initiated model for skin carcinogenesis. Following low-dose application of 12-O-tetradecanoyl phorbol-13-acetate (TPA), a marked increase in the number of skin papillomas occurred in transgenic mice receiving arsenic in the drinking water as compared to control drinking water. Papillomas did not develop in arsenic-treated transgenic mice that had not received TPA or arsenic-treated wild-type FVB/N mice, suggesting that arsenic is neither a tumor initiator or promoter but rather an enhancer. Injection of anti-GM-CSF antibodies following application of TPA in transgenic mice reduced the number of papillomas. Consistent with that observed in human keratinocyte cultures, increases in GM-CSF and TGF-alpha mRNA transcripts were found within the epidermis of arsenic-treated mice when compared to controls within 6 weeks of treatment. These results suggest that arsenic enhances papilloma development via the chronic stimulation of keratinocyte-derived growth factors and represents the first example of a chemical carcinogen that acts in this manner. These studies suggest that in vitro studies with human keratinocyte cultures examined in conjunction with TG.AC transgenic mice can provide a useful model for examining the tumor enhancing properties of environmental chemicals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219559     DOI: 10.1016/s1383-5742(97)00006-9

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  31 in total

1.  Arsenic exposure and toxicology: a historical perspective.

Authors:  Michael F Hughes; Barbara D Beck; Yu Chen; Ari S Lewis; David J Thomas
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

2.  Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh.

Authors:  Yu Chen; Faruque Parvez; Mary Gamble; Tariqul Islam; Alauddin Ahmed; Maria Argos; Joseph H Graziano; Habibul Ahsan
Journal:  Toxicol Appl Pharmacol       Date:  2009-01-27       Impact factor: 4.219

3.  Overabundance of putative cancer stem cells in human skin keratinocyte cells malignantly transformed by arsenic.

Authors:  Yang Sun; Erik J Tokar; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2011-10-19       Impact factor: 4.849

4.  Arsenic transformation predisposes human skin keratinocytes to UV-induced DNA damage yet enhances their survival apparently by diminishing oxidant response.

Authors:  Yang Sun; Chikara Kojima; Colin Chignell; Ronald Mason; Michael P Waalkes
Journal:  Toxicol Appl Pharmacol       Date:  2011-07-21       Impact factor: 4.219

5.  Opposing actions of insulin and arsenite converge on PKCdelta to alter keratinocyte proliferative potential and differentiation.

Authors:  Tatiana V Reznikova; Marjorie A Phillips; Timothy J Patterson; Robert H Rice
Journal:  Mol Carcinog       Date:  2010-04       Impact factor: 4.784

Review 6.  Oxidative mechanism of arsenic toxicity and carcinogenesis.

Authors:  Honglian Shi; Xianglin Shi; Ke Jian Liu
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

7.  p53 expression in circulating lymphocytes of non-melanoma skin cancer patients from an arsenic contaminated region in Mexico. A pilot study.

Authors:  Ana M Salazar; Emma Calderón-Aranda; Mariano E Cebrián; Monserrat Sordo; Andrés Bendesky; Arístides Gómez-Muñoz; Leonor Acosta-Saavedra; Patricia Ostrosky-Wegman
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

8.  Arsenic exposure in utero exacerbates skin cancer response in adulthood with contemporaneous distortion of tumor stem cell dynamics.

Authors:  Michael P Waalkes; Jie Liu; Dori R Germolec; Carol S Trempus; Ronald E Cannon; Erik J Tokar; Raymond W Tennant; Jerrold M Ward; Bhalchandra A Diwan
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

Review 9.  Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium.

Authors:  Konstantin Salnikow; Anatoly Zhitkovich
Journal:  Chem Res Toxicol       Date:  2007-10-30       Impact factor: 3.739

10.  Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice.

Authors:  Gene J Ahlborn; Gail M Nelson; Rachel D Grindstaff; Michael P Waalkes; Bhalchandra A Diwan; James W Allen; Kirk T Kitchin; R Julian Preston; Araceli Hernandez-Zavala; Blakely Adair; David J Thomas; Don A Delker
Journal:  Toxicology       Date:  2009-05-18       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.